Vorasidenib Maintenance for IDH Mutant Astrocytoma

Abroad (travel likely)RecruitingPHASE3

Conditions

IDH-mutant Grade 2 or 3 Astrocytoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Medical University of Innsbruck, Innsbruck, Austria

  • Kepler University Hospital - Neuromed campus, Linz, Austria

  • Medical University of Vienna, Vienna, Austria

  • Universitair Ziekenhuis Brussel, Brussels, Belgium

  • Ghent University Hospital, Ghent, Belgium

  • U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium

  • Masaryk Memorial Cancer Institute, Brno, Czechia

  • Universitary hospital Bordeaux France, Bordeaux, France

  • CHU Lyon - Hopital neurologique Pierre Wertheimer, Lyon, France

  • Marseille APHM, Marseille, France

  • Assistance Publique Hopitaux de Paris APHP - Sorbonne, Paris, France

  • Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France

  • Universitaskliniken Bonn, Bonn, Germany

  • University Hospital Frankfurt -Senckenberg Institute of Neurooncology, Frankfurt, Germany

  • NNeurology department heidelberg, Heidelberg, Germany

  • Mannheim University Hospital, Mannheim, Germany

  • Universitaetsklinikum Regensburg, Regensburg, Germany

  • Bellaria Hospital, IRCCS Istituto delle Scienze Neurologiche - AUSL di Bologna, Bologna, Italy

  • Veneto Institute of Oncology, Padova, Italy

  • Sapienza University, Roma, Italy

  • AOU Citta della Salute e della Scienza di Torino, Torino, Italy

  • Amsterdam UMC location VUMC, Amsterdam, Netherlands

  • Academisch Ziekenhuis Maastricht, Maastricht, Netherlands

  • Erasmus MC, Rotterdam, Netherlands

  • Hospital de Sant Pau i La Santa Creu, Barcelona, Spain

  • Vall de Hebron Hospital, Barcelona, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • University Hospital Basel, Basel, Switzerland

  • University Hospital Zurich, Zurich, Switzerland

  • Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

  • The Christie NHS Foundation Trust, Manchester, United Kingdom

  • Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, United Kingdom

  • Royal Marsden Hospital, Surrey Quays, United Kingdom

Study leads
  • Matthias Preusser

    Study Chair

    Universitaetsklinikum Wien - AKH uniklinieken, Vienna, Austria.

  • Marjolein Geurts

    Study Chair

    Brain Tumour Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.